Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Altimmune Inc (NASDAQ: ALT) closed at $5.17 in the last session, up 0.58% from day before closing price of $5.14. In other words, the price has increased by $0.58 from its previous closing price. On the day, 2.55 million shares were traded. ALT stock price reached its highest trading level at $5.31 during the session, while it also had its lowest trading level at $5.1.
Ratios:
We take a closer look at ALT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.18 and its Current Ratio is at 17.18. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $18.Stifel initiated its Buy rating on January 08, 2025, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Sohn Catherine A. bought 1,000 shares for $5.78 per share. The transaction valued at 5,784 led to the insider holds 1,000 shares of the business.
WEAVER GREGORY L bought 10,000 shares of ALT for $51,996 on Mar 13 ’25. The Chief Financial Officer now owns 10,000 shares after completing the transaction at $5.20 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 539450112 and an Enterprise Value of 344123072. For the stock, the TTM Price-to-Sale (P/S) ratio is 26972.50 while its Price-to-Book (P/B) ratio in mrq is 2.66. Its current Enterprise Value per Revenue stands at 17206.154 whereas that against EBITDA is -3.809.
Stock Price History:
The Beta on a monthly basis for ALT is -0.06, which has changed by -0.3967328 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $10.88, while it has fallen to a 52-week low of $2.90. The 50-Day Moving Average of the stock is 26.22%, while the 200-Day Moving Average is calculated to be 9.14%.
Shares Statistics:
According to the various share statistics, ALT traded on average about 2.88M shares per day over the past 3-months and 3278860 shares per day over the past 10 days. A total of 104.34M shares are outstanding, with a floating share count of 103.50M. Insiders hold about 0.81% of the company’s shares, while institutions hold 40.02% stake in the company. Shares short for ALT as of 1763078400 were 23285097 with a Short Ratio of 8.07, compared to 1760486400 on 21503786. Therefore, it implies a Short% of Shares Outstanding of 23285097 and a Short% of Float of 22.45.
Earnings Estimates
. The current rating of Altimmune Inc (ALT) reflects the combined expertise of 7.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.22 and low estimates of -$0.31.
Analysts are recommending an EPS of between -$0.97 and -$1.04 for the fiscal current year, implying an average EPS of -$0.99. EPS for the following year is -$1.32, with 7.0 analysts recommending between -$1.03 and -$1.82.
